Hjem › Astrocytom › Massachusetts › Boston
Kliniske studier for Astrocytom i Boston, MA
13 studier for Astrocytom søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekruttererFase 1/2
- Research Site, Boston
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
- Tufts Medical Center, Boston
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservasjonsstudie
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Rekrutterer
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruttererFase 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Dana-Farber Cancer Institute, Boston
Implantable Microdevice In Primary Brain Tumors
RekruttererTidlig fase 1
- Brigham and Women's Hospital, Boston
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
RekruttererObservasjonsstudie
- Massachusetts General Hospital, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
RekruttererObservasjonsstudie
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
RekruttererObservasjonsstudie
- Massachusetts General Hospital, Boston
Astrocytom-studier i andre byer
- Houston, TX14 studier
- New York City, NY9 studier
- Chicago, IL9 studier
- Miami, FL7 studier
- Philadelphia, PA7 studier
- Columbus, OH6 studier
- San Francisco, CA6 studier
- Washington, DC6 studier
- Durham, NC6 studier
- Seattle, WA6 studier
- Salt Lake City, UT5 studier
- Aurora, CO5 studier
Andre studier i Boston
- Brystkreft112 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)85 studier
- Metastatisk kreft63 studier
- Kolorektal kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.